Skip to Content
Merck
CN
  • Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.

Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.

Journal of medicinal chemistry (2010-02-11)
Valentina Onnis, Cenzo Congiu, Emmelie Björklund, Franziska Hempel, Emma Söderström, Christopher J Fowler
ABSTRACT

Fatty acid amide hydrolase (FAAH) is the key hydrolytic enzyme for the endogenous cannabinoid receptor ligand anandamide. The synthesis and evaluation for their FAAH inhibitory activities of a series of 18 paracetamol esters are described. Structure-activity relationship studies indicated that the ester (33) with a 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetic acid substituent was the most potent analogue in this series. The compound inhibited FAAH activity in a competitive manner with a K(i) value of 0.16 microM. The compound was also able to inhibit the FAAH activity in rat basophilic leukemia cells as assessed by measuring either the hydrolysis of anandamide, the FAAH-dependent cellular accumulation of anandamide, or the FAAH-dependent recycling of tritium to the cell membranes. The compound also inhibited the activity of monoacylglycerol lipase (MGL), the enzyme responsible for the hydrolysis of the endogenous cannabinoid receptor ligand 2-arachidonoylglycerol, with an IC(50) value of 1.9 microM. It is concluded that the compound may be a useful template for the design of potent novel inhibitors of FAAH.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ibuprofen
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Ibuprofen, meets USP testing specifications
Sigma-Aldrich
Ibuprofen, ≥98% (GC)
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
(S)-(+)-Ibuprofen, ReagentPlus®, 99%